News from ICON plc
Category: Neurology News
VERITON PHARMA LTD New company name for Special Products Ltd
News from Veriton Pharma
Epistatus® 10mg oromucosal solution Midazolam now available to prescribe
News from Veriton Pharma
Applied EEG Neuroscience specialists BrainTrainUK launches new QEEG service
News from BrainTrainUK
Neurological Advocacy Service is two years’ old
Neurology Advocacy Service
NHS England partners with Merck on a commercial agreement that allows people with MS in England immediate access to cladribine tablets (Mavenclad®)
News from Merck
Veriton Pharma Ltd – New company name for Special Products Ltd
Press release on behalf of Veriton Pharma LtdPublished online: 2/10/17 Veriton Pharma Ltd is announced as the new company name for Special Products Ltd. This name change has occurred both to incorporate the company’s past heritage with its future ambitions to make trusted medicines available for everyday living. The Chief Commercial Officer commented: With the launch of…
Epistatus® 10 mg Oromucosal Solution Midazolam – Now Available To Prescribe
Press release on behalf of Special Products Ltd
Mavenclad (Cladribine Tablets) Demonstrates Sustained Disease Control over 4 Years
Press release on behalf of Merck
